DC Circ. Revives K-V's FDA Enforcement Row
The D.C. Circuit on Tuesday revived K-V Pharmaceutical Co.'s suit attempting to force the U.S. Food and Drug Administration to block pharmacies from producing cheaper compounded versions of K-V's preterm-birth prevention...To view the full article, register now.
Already a subscriber? Click here to view full article